◼ Archived
Business
🔮 fades ✗
11% of Americans Are Currently Taking a GLP-1 Weight Loss Drug Like Wegovy
GLP-1 weight loss drugs are being used by a record number of Americans.
Weight Loss
13 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Health
🔮 fades ✓
Eight-hour eating window sustains long-term weight loss - News-Medical
New research suggests an eight-hour eating window may be key to maintaining long-term weight loss.
◼ Archived
Health
🔮 fades ✓
Peptide hype is at an all-time high
Peptides have emerged as a dominant wellness trend, sparking a commercial gold rush alongside growing warnings about unregulated black-market usage.
◼ Archived
Health
🔮 fades ✓
GLP-1 RAs May Reduce Metastatic Progression in Certain Obesity-Related Cancers
Recent studies suggest GLP-1 receptor agonists may slow cancer progression in obesity-related cases.
◼ Archived
Health
🔮 holds ✗
As weight loss drugs like Ozempic spread, Louisiana doctors, researchers help answer big questions
Researchers and doctors are exploring the broader implications of GLP-1 weight loss drugs as their use becomes more widespread.
◼ Archived
Business
🔮 fades ✓
Seniors in Medicare are about to get landmark obesity drug coverage
Starting July 1, 2026, Medicare will cover GLP-1 weight-loss drugs for seniors, marking a significant expansion in obesity treatment access.
◼ Archived
Business
🔮 fades ✓
Why breakthrough GLP-1 weight loss pills may be a bad thing for employer insurance coverage
Employers are reconsidering coverage for popular GLP-1 weight loss drugs, leaving patients and insurers in limbo.
◼ Archived
Health
🔮 holds ✗
GLP-1 weight loss drugs may be misused by patients with eating disorders: Study
New research indicates that GLP-1 receptor agonists, including Ozempic, are being misused by individuals with eating disorders.
◼ Archived
Health
🔮 fades ✓
Effects of exercise and liraglutide on vascular health and inflammation during weight loss maintenance: a prespecified secondary analysis of the S-LiTE trial
New research reveals the combined effects of exercise and liraglutide on vascular health and inflammation during weight loss maintenance.
◼ Archived
Health
🔮 fades ✓
Intermittent Fasting vs. Calorie Count: Which Is Best for Weight Loss?
Intermittent fasting is gaining traction as a potential alternative to calorie counting for weight loss.
◼ Archived
Health
🔮 fades ✓
Eli Lilly and Company (LLY) CEO on How GLP-1s Will Reshape America
Eli Lilly's CEO discusses the potential impact of GLP-1 pills on America's health landscape.
◼ Archived
Health
🔮 fades ✓
Doctor debunks 'nature's Ozempic' gelatin trend going viral on social media
Medical professionals are debunking a viral social media trend promoting gelatin drinks as a 'natural Ozempic' for weight loss.
◼ Archived
Health
🔮 fades ✓
The Actual Benefits of Intermittent Fasting, According to Experts
Intermittent fasting is trending as a weight-loss strategy, but experts caution it's not for everyone.